This special feature describes basic skills for evaluating outcomes studies and the appropriate application of outcome studies to clinical practice. The authors (1) explain the difference between a randomized controlled clinical trial and an outcome study; (2) define clinical, economic, and humanistic outcomes; (3) describe four common types of economic studies; and (4) list the steps involved in evaluating and interpreting an outcomes study.
KozmaC.M., ReederC.E., SchulzR.M.Economic, clinical and humanistic outcomes; a planning model for pharmacoeconomic research. Clin Ther.1993; 15: 1121–32.
The GUSTO Investigators.An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction. N Engl J Med.1993; 329: 673–82.
7.
HeylandD.K., GafniA., KernermanP.How to use the results of an economic evaluation. Crit Care Med.1999; 27: 1195–1202.
KozmaC.M.Consideration of cost-consequence ratios as an emerging tool in pharmacoeconomic decision making. New Medicine.1997; 1: 35–9.
10.
DoubiletP., WeinsteinM.C., McNeilB.J.Use and misuse of the term “cost-effective” in medicine. N Engl J Med.1986; 314(2): 253–6.
11.
LaheijR.J., SeverenceJ.L., van de LisdonkE.H.Randomized controlled trial of omeprazole or endoscopy in patients with persistent dyspepsia: a cost-effectiveness analysis. Aliment Pharmacol Ther.1998; 12: 1249–56.
12.
KoplanJ.P., PrebladS.R.A benefit-cost analysis of mumps vaccines. Am J Dis Child.1982; 136: 362–4.
13.
LieuT.A., CochiS.L., BlackS.B.Cost-effectiveness of a routine varicella vaccination program for US children. JAMA.1994; 271: 375–81.
14.
In: BungayK.M., OsterhausJ.T., PaladinoJ.A.., eds. Pharmacoeconomics and Outcomes: Applications for Patient Care: Module 2. Assessment of Economic Outcomes.1st ed.Kansas City, MO: American College of Clinical Pharmacy; 1996.
15.
FrybackD.G., DasbachE.J., KleinR.The Beaver Dam Health Outcomes Study: Initial catalog of health state quality factors. Med Decis Making.1993; 13: 89–102.
16.
LeeJ.T., SanchezL.A.Interpretation of “cost-effective”and soundness of economic evaluations in pharmacy literature. Am J Hosp Pharm.1992; 48: 2622–7.
17.
UdvarhelyiS.I., ColditzG.A., RaiA.Cost-effectiveness and cost-benefit analyses in the medical literature. Ann Intern Med.1992; 116: 238–44.
18.
DrummondM.F., RichardsonS., O'BrienB.J.Users' guide to the medical literature. JAMA.1997; 277: 1552–7.
19.
RevickiD.A., FrankL.Pharmacoeconomic evaluation in the real world. Pharmacoeconomics.1999; 15: 423–34.
20.
SacristanJ.A., SotoJ., GalendeI.Evaluation of pharmacoeconomic studies: utilization of a checklist. Ann Pharmacother.1993; 27: 1126–33.
21.
SanchezL.A.Applied pharmacoeconomics: evaluation and use of pharmacoeconomic data from the literature. Am J Health-Syst Pharm.1999; 56: 1630–40.
22.
MilneR.J.Evaluation of the pharmacoeconomic literature. Pharmacoeconomics.1994; 6: 337–45.
23.
JolicoueurL.M., Jones-GrizzleA.J., BoyerJ.G.Guidelines for performing a pharmacoeconomic analysis. Am J Hosp Pharm.1992; 49: 1741–7.
24.
HillS.R., MitchellA.S., HenryD.A.Problems with the interpretation of pharmacoeconomic analyses. JAMA.2000; 283: 2116–21.
